BioSpace News Archive

Policy

Duchesnay Inc. Receives Approval of Supplemental New Drug Application (sNDA) to Add Moderate to Severe Vaginal Dryness, a Symptom of Vulvar and Vaginal Atrophy (VVA) Due to Menopause, to the Indication of Osphena® (ospemifene)

Duchesnay Inc. announced today that the FDA has approved its supplemental New Drug Application (sNDA) seeking to add moderate to severe vaginal dryness, a symptom of vulvar and vaginal atrophy (VVA), due to menopause, to the indication of Osphena® (ospemifene).

January 29, 2019
·
4 min read
Geyser Brands First Crop is in the Ground

Geyser Brands Inc. announces that the Company has planted it first crop under Heath Canada’s license to cultivate.

January 29, 2019
·
3 min read
Business

Cannabis Lifestyle Brand Old Pal Hires New Top Executive Leaders

Old Pal has added three top executive leaders to its list of best in class new hires as they continue to position the company for unprecedented growth in 2019.

January 29, 2019
·
3 min read
Morneau Shepell finds increase in workplace and personal stress, while sense of stigma declines

Employees and managers report increased stress, in part led by an increased feeling of workplace isolation

January 29, 2019
·
7 min read
Pharm Country

Healthy Meals Supreme’s Customized, Culinary Medicine Inspired Meals Debut in the Northeast Region of the US

No Subscription Required to Purchase: Introductory offer - 50% OFF and FREE SHIPPING

January 29, 2019
·
3 min read
Deals

Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision

Addition of Phase 3-Ready Clinical Program

January 29, 2019
·
7 min read
Pharm Country

Koneksa CEO Joined Faculty at Keystone Symposium on Digital Health

Chris Benko Presented on Using Wearable Technology in Clinical Trials

January 29, 2019
·
2 min read
BioCapital

New HealthWell Foundation Fund Assists Medicare Patients Living with Nontuberculous Mycobacterium

Copayment and Premium Assistance Now Available

January 29, 2019
·
3 min read
Business

WCG Partners with Prudentia Group to Enhance Drug Safety in Clinical Development

Top global consultancy teams with leading pharmacovigilance service provider to deliver seamless suite of safety solutions to accelerate clinical research

January 29, 2019
·
3 min read
Pharm Country

“Smarter” Genetic Risk Testing from RDx BioScience Enhances Safe, Cost Effective Pain Management and High-Quality Addiction Care

RDx BioScience (RDx) points to the important role of pharmacogenomic (PGx) testing in the workplace, optimizing safe, cost-effective pain management and addiction treatment to help address issues related to opioid addiction.

January 29, 2019
·
2 min read